Sign in

CIK 0001367644

  • Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
141902018
Phone
+1 240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
  1. 4 Open-market sale President & CEO sold 63,209 shares at an average $39.06 ($2,468,633)
  2. 4 Shares withheld for taxes President & CEO gave up 2,641 shares (to pay taxes)
  3. 4 Open-market sale Chairman sold 17,871 shares at $37.50 ($670,163)
  4. 4 Open-market sale EVP, Biosciences Div. sold 3,376 shares at $36.50 ($123,224)
  5. 4 Open-market sale Chairman sold 13,013 shares at $36.50 ($474,975)
  6. 4 Open-market sale EVP, Biosciences Div. sold 36,126 shares at an average $35.64 ($1,287,586)
  7. 4 Open-market sale Chairman sold 13,225 shares at $35.50 ($469,488)
  8. 4 Open-market sale Chairman sold 13,450 shares at $34.50 ($464,025)
  9. 4 Shares withheld for taxes EVP, Corporate Services Div gave up 1,234 shares (to pay taxes)
  10. 4 Open-market sale Chairman sold 13,689 shares at $33.50 ($458,582)
  11. 4 Open-market sale Director sold 6,080 shares at an average $32.37 ($196,797)
  12. 4 Open-market sale Director sold 7,200 shares at $34.72 ($249,984)
  13. 4 Open-market sale Director sold 4,922 shares at $36.00 ($177,192)
  14. 4 Open-market sale Chairman sold 30,000 shares at $35.50 ($1,065,000)
  15. 4 Open-market sale Chairman sold 29,766 shares at $34.50 ($1,026,927)
  16. 4 Open-market sale Chairman sold 234 shares at $34.50 ($8,073)
  17. 4 Open-market sale Director sold 4,922 shares at $34.00 ($167,348)
  18. 4 Open-market sale Director sold 4,923 shares at $32.76 ($161,277)
  19. 4 Exercise or conversion EVP, Biodefense Divison acquired 10,238 shares (option exercise)
  20. 4 Open-market sale Chairman sold 74,564 shares at an average $32.60 ($2,431,048)

Page 26 of 49 · 970 filings